Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dalgarno

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|January 5, 2002
Src inhibitors: genomics to therapeuticsT Sawyer, B Boyce, D Dalgarno, et al.
The Journal of Biological Chemistry|September 5, 1992
An active covalently linked dimer of human interferon-gamma. Subunit orientation in the native proteinC A Lunn, L Davies, D Dalgarno, et al.
Protein Engineering|February 1, 1991
The carboxyl-terminal region of human interferon gamma is important for biological activity: mutagenic and NMR analysisD Lundell, C Lunn, D Dalgarno, et al.
Protein Engineering|April 1, 1992
A point mutation of human interferon gamma abolishes receptor recognitionC A Lunn, J Fossetta, D Dalgarno, et al.
Journal of Clinical Pharmacology|August 16, 2001
Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteersJ D Iuliucci, S D Oliver, S Morley, et al.
Organic Letters|July 25, 2000
Selective epimerization of rapamycin via a retroaldol/aldol mechanism mediated by titanium tetraisopropoxideW Yang, C A Digits, M Hatada, et al.
Journal of Medicinal Chemistry|March 29, 2000
Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocketW Yang, L W Rozamus, S Narula, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activityW Shakespeare, M Yang, R Bohacek, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|January 5, 2002
Src inhibitors: genomics to therapeuticsT Sawyer, B Boyce, D Dalgarno, et al.
The Journal of Biological Chemistry|September 5, 1992
An active covalently linked dimer of human interferon-gamma. Subunit orientation in the native proteinC A Lunn, L Davies, D Dalgarno, et al.
Protein Engineering|February 1, 1991
The carboxyl-terminal region of human interferon gamma is important for biological activity: mutagenic and NMR analysisD Lundell, C Lunn, D Dalgarno, et al.
Protein Engineering|April 1, 1992
A point mutation of human interferon gamma abolishes receptor recognitionC A Lunn, J Fossetta, D Dalgarno, et al.
Journal of Clinical Pharmacology|August 16, 2001
Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteersJ D Iuliucci, S D Oliver, S Morley, et al.
Organic Letters|July 25, 2000
Selective epimerization of rapamycin via a retroaldol/aldol mechanism mediated by titanium tetraisopropoxideW Yang, C A Digits, M Hatada, et al.
Journal of Medicinal Chemistry|March 29, 2000
Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocketW Yang, L W Rozamus, S Narula, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2000
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activityW Shakespeare, M Yang, R Bohacek, et al.
Pageof 1